Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.675 USD | +3.89% | -2.20% | +28.43% |
May. 29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
May. 29 | Pulmatrix, Inc. Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation | CI |
Evolution of the average Target Price on MannKind Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering MannKind Corporation
Oppenheimer | |
Wedbush | |
HC Wainwright | |
SVB Securities LLC | |
RBC Capital Markets | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- MNKD Stock
- Consensus MannKind Corporation